Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JN.1.46NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.48NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.47.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.47.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.7.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.28NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.29NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.29NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.7.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KV.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KV.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.1.16.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.16.15NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
EG.5.1.14NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.14NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.7.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.9NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KW.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
MF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MF.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
LF.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LF.2NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
KR.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KR.3NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
LQ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LQ.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XDK.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDK.5NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.4.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.4.8NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JF.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
XBB.2.3.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.19NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JD.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.52NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.52NSC2CCTTGTGTGGTCTGCATGAGTTTAG25482955429530R-26482.3US
JN.1.42NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used